This test is most useful if any of these apply to you.
If you live somewhere with water touched by firefighting foam, or you work around it, this is one way to check whether a long-lasting industrial chemical has found its way into your body. It belongs to a large family of synthetic compounds that resist breaking down and can linger in people for years.
A urine result here mainly signals recent or ongoing exposure. This is a research-stage measurement without agreed-upon healthy ranges, so a single number is a starting point, not a verdict.
PFHpS (perfluoro-1-heptane sulfonic acid) is a man-made compound from the group called PFAS (per- and polyfluoroalkyl substances), the forever chemicals used in firefighting foams, stain and water repellents, and industrial processes. Your body does not make it, so every molecule in you came from the outside environment.
It sits in the longer-chain, more persistent branch of this family. That matters because once it is in you, it leaves slowly, over years rather than days.
Because this chemical is so persistent and leaves the body mostly through routes other than urine, a urine sample captures a thin slice of your total burden. In paired testing across the U.S. population, PFAS were undetectable in urine for about two-thirds of people (67.5%), and in heavily exposed workers urinary levels ran far below blood levels. Blood or serum is the more complete window on how much of this chemical you carry.
Sensitive lab methods can still pick it up in urine. In blood, it shows up in nearly everyone tested, for example 96.4% of Wisconsin adults and 66.1% of a Norwegian pregnancy group, but those are serum figures, not urine detection rates. A detectable urine level points more toward current or recent exposure than toward a lifetime total.
The most direct urine-based health signal comes from a study of adults in Northeast China. Urinary levels of this chemical were significantly higher in people with nodular goiter, a lumpy enlargement of the thyroid, than in those without it.
In that same study a closely related chemical, PFHxS, carried the stronger statistical signal once other factors were accounted for. So the link for this specific chemical is suggestive rather than settled.
Most pregnancy findings come from blood or plasma, not urine, so treat them as related evidence rather than direct proof about a urine result. In one nested study, women with the highest plasma levels had about 80% higher odds of miscarriage than those with the lowest (odds ratio 1.8), though the finding was borderline, with the confidence interval reaching down to about 1.0.
A meta-analysis linked higher exposure to lower birth weight, and this chemical showed the largest per-step reduction of any PFAS examined (about 181 grams lower birth weight per unit increase), along with weaker signals for shorter pregnancy length and preterm birth.
Among people with liver disease, higher blood levels of this chemical tracked with elevated liver enzymes (ALP, alkaline phosphatase, and AST, aspartate aminotransferase) and with AFP (alpha-fetoprotein), a protein that can rise with liver damage. In U.S. adults who drink heavily, higher levels were tied to about 44% higher odds of alcohol-related fatty liver disease. These findings come from blood, not urine.
In a case-control study of Brazilian women, those with the highest plasma levels had about twice the odds of breast cancer as those with the lowest, with a stronger link to hormone-receptor-positive tumors. This is plasma-based and early evidence. Larger meta-analyses have generally not found a clear overall link between PFAS and breast cancer, so treat this as a single suggestive finding rather than a settled association.
Kidney function shapes the levels of this chemical in a way that trips up simple reading. In U.S. adults, blood levels rose as kidney filtration slipped into the mild-to-moderate range, peaked around moderate impairment, then dropped sharply at more severe stages.
This is not a clean line where worse kidneys always mean higher chemical, and that is exactly why this marker should not be read like a standard lab value. The level reflects a shifting balance between the kidney pulling the chemical back into the body and flushing it out, layered on top of how much exposure you have had. A single reading blends exposure and biology, so context matters more than the raw number. Men also tend to carry more than women, roughly 60% higher in one national sample, partly because pregnancy, breastfeeding, and menstruation give women extra routes to shed these chemicals.
Because urine reflects recent exposure, the most useful thing you can do is watch the direction over time rather than fixate on one value. If you remove a suspected source, such as switching off contaminated tap water, a falling urine level over months suggests your exposure is dropping.
Get a baseline, retest in 3 to 6 months if you have changed your water source or environment, then at least yearly if you remain in a higher-exposure setting. Keep in mind that blood testing may track your stored burden better than urine, because this chemical clears over years.
A detectable or rising urine level is a prompt to investigate exposure, not to panic. Start with your drinking water, especially if you live near an airport, military base, or industrial site that has used firefighting foam. Because urine understates total burden, pairing this with a blood PFAS panel gives a fuller picture.
If your result is high, consider companion testing of kidney function (eGFR and cystatin C), thyroid function (TSH), and liver enzymes, and bring the numbers to a clinician familiar with environmental exposures, such as a medical toxicologist.
Evidence-backed interventions that affect your Perfluoro-1-heptane sulfonic acid (PFHpS) level
Perfluoro-1-heptane sulfonic acid (PFHpS) is best interpreted alongside these tests.
Perfluoro-1-heptane sulfonic acid (PFHpS) is included in these pre-built panels.